Search clinical trials for: RAD001H

Total 2 results

Novartis Pharmaceuticals

Completed

Efficacy and Safety of Everolimus in Liver Transplant Recipients of Living Donor Liver Transplants

Liver Transplantation

United States, Japan, Saudi Arabia, Taiwan, Egypt, Italy, Korea, Republic of, Germany, India, Canada, Russian Federation, Singapore, Turkey
Novartis Pharmaceuticals

Withdrawn

Study of the Effect of Everolimus Immunosuppressive Combination Therapies on Renal Function When Used as a Maintenance Treatment for Liver Transplant Patients. (Prometheus)

Liver Transplantation

3

Subscribe